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Abstract
Oral-Facial-Digital Syndrome type VI (OFD VI) represents a rare phenotypic subtype of Joubert syndrome and
related disorders (JSRD). In the original report polydactyly, oral findings, intellectual disability, and absence of the
cerebellar vermis at post-mortem characterized the syndrome. Subsequently, the molar tooth sign (MTS) has been
found in patients with OFD VI, prompting the inclusion of OFD VI in JSRD. We studied the clinical,
neurodevelopmental, neuroimaging, and genetic findings in a cohort of 16 patients with OFD VI. We derived the
following inclusion criteria from the literature: 1) MTS and one oral finding and polydactyly, or 2) MTS and more
than one typical oral finding. The OFD VI neuroimaging pattern was found to be more severe than in other JSRD
subgroups and includes severe hypoplasia of the cerebellar vermis, hypoplastic and dysplastic cerebellar
hemispheres, marked enlargement of the posterior fossa, increased retrocerebellar collection of cerebrospinal fluid,
abnormal brainstem, and frequently supratentorial abnormalities that occasionally include characteristic
hypothalamic hamartomas. Additionally, two new JSRD neuroimaging findings (ascending superior cerebellar
peduncles and fused thalami) have been identified. Tongue hamartomas, additional frenula, upper lip notch, and
mesoaxial polydactyly are specific findings in OFD VI, while cleft lip/palate and other types of polydactyly of hands
and feet are not specific. Involvement of other organs may include ocular findings, particularly colobomas. The
majority of the patients have absent motor development and profound cognitive impairment. In OFD VI, normal
cognitive functions are possible, but exceptional. Sequencing of known JSRD genes in most patients failed to
detect pathogenetic mutations, therefore the genetic basis of OFD VI remains unknown. Compared with other
JSRD subgroups, the neurological findings and impairment of motor development and cognitive functions in OFD
VI are significantly worse, suggesting a correlation with the more severe neuroimaging findings. Based on the
literature and this study we suggest as diagnostic criteria for OFD VI: MTS and one or more of the following: 1)
tongue hamartoma(s) and/or additional frenula and/or upper lip notch; 2) mesoaxial polydactyly of one or more
hands or feet; 3) hypothalamic hamartoma.
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Joubert Syndrome (JS) is a rare midbrain-hindbrain mal-
formation with an estimated prevalence between 1:80
000 and 1:100 000 live births [1]. The characteristic neu-
rological signs of JS include muscular hypotonia (most
prominent during infancy), cerebellar ataxia (typically
developing later), ocular motor apraxia, and an irregular
breathing pattern in the neonatal period [2-4]. Addition-
ally, cognitive functions are impaired in almost all
patients [5]. The so-called molar tooth sign (MTS) is a
consistent and pathognomonic neuroanatomical feature
of JS [6-9]. The MTS is characterized by thickened,
elongated, and horizontally located superior cerebellar
peduncles (SCP) and an abnormally deep interpeduncu-
lar fossa. Involvement of the kidneys (nephronophthisis
and/or renal cysts), liver (congenital liver fibrosis), and
eyes (retinal dystrophy and/or ocular colobomas) may
be associated features of JS, defining the spectrum of so-
called JS-related disorders (JSRD) [2-4]. At present, cau-
sative mutations in 13 genes have been associated with
JSRD (JBTS1/INPP5E,J B T S 2 / TMEM216,J B T S 3 / AHI1,
JBTS4/NPHP1, JBTS5/CEP290, JBTS6/TMEM67, JBTS7/
RPGRIP1L,J B T S 8 / ARL13B,J B T S 9 / CC2D2A,J B T S 1 0 /
OFD1, JBTS12/KIF7, JBTS13/TCTN1 and the TCTN2
gene) [4,10-12]. Additionally, heterozygous, not causa-
tive mutations have been found in the JBTS11/TTC21B
gene [13]. All JSRD genes encode for proteins of the pri-
mary cilium. Primary cilia are subcellular organelles
k n o w nt op l a yk e yr o l e si nt h ed e v e l o p m e n ta n df u n c -
tioning of several cell types, including retinal photore-
ceptors, neurons, and the epithelial cells lining kidney
tubules and bile ducts [14-16].
Based on the extent of multiorgan involvement, six
phenotypes of the JSRD spectrum have been recently
defined: 1) “pure” JS (purely neurological without retinal,
renal, or liver involvement); 2) JS with ocular defect (neu-
rological features associated with retinal dystrophy); 3) JS
with renal defect (neurological features with renal invol-
vement, mostly nephronophthisis); 4) JS with oculorenal
defects (association of neurological signs with both retinal
dystrophy and nephronophthisis); 5) JS with hepatic
defect (neurological features with congenital liver fibro-
sis); and 6) JS with oral-facial-digital defects [4].
The sixth JSRD phenotype represents the Oral-Facial-
Digital Syndrome type VI (OFD VI) or Váradi-Papp syn-
drome (OMIM 277170). The original description in the
pre-MRI era included polydactyly, oral findings, intellec-
tual disability, and absence of the cerebellar vermis at
post-mortem [17]. Subsequently, MTS has been found
in patients with OFD VI prompting the inclusion of
OFD VI in JSRD [8,18]. Additionally, hypothalamic
hamartomas were reported as a characteristic, but not
consistent part of OFD VI [8,18-20]. Absence of the
pituitary gland was described in two siblings [8,18-20].
To date no diagnostic criteria for OFD VI have been
proposed.
Based on the largest cohort of OFD VI patients col-
lected so far, we aimed to: 1) evaluate the spectrum of
neuroimaging findings, 2) characterize the neurological
and dysmorphic features, the involvement of other
organs, and the neurodevelopmental outcome, 3)
describe the results of genetic screening, and 4) suggest
diagnostic criteria.
Patients and Methods
Patient cohort
The patients included in this study were collected by the
senior authors (EMV and EB): 1) from their personal
cohorts of OFD VI patients; 2) from patients who were
referred for second opinion; 3) from requests to evaluate
clinical and neuroimaging data of patients with a defi-
nite or probable diagnosis of OFD VI; and 4) from
patients referred for molecular genetic testing after a
diagnosis of OFD VI. The inclusion criteria were:
1. MTS and one oral finding (one or multiple tongue
hamartomas, or multiple prominent frenula, or cleft lip/
palate) and polydactyly (pre-, meso-, or postaxial), or
2. MTS and more than one typical oral finding.
Inclusion criterion 2 was derived from the literature
suggesting that oral findings are consistently present in
and diagnostic for OFD VI in the context of JSRD.
Neuroimaging analysis
All available imaging data sets were retrospectively stu-
died and evaluated by two pediatric neurologists with
experience in JSRD (AP and EB). The same evaluation
approach was adopted as in the recent study of neuroi-
maging findings in 75 patients with JSRD [21].
Infratentorial image analysis
The infratentorial evaluation included qualitative assess-
ment of the size (degree of hypoplasia) and morphology
(normal or folial disorganization) of the cerebellar ver-
mis and hemispheres (judged as normal, reduced, or
enlarged by visual evaluation). The extent of vermian
hypoplasia was graded according to Quisling et al [7].
On sagittal images the size and shape of the fourth
ventricle was evaluated. On axial images the width of
the interhemispheric cleft was measured and graded
("slit” if narrower than 1 mm, 1-2 mm, or wider than 2
mm). The posterior fossa was qualitatively evaluated on
sagittal images, including size (normal or enlarged), pre-
sence of increased retrocerebellar cerebrospinal fluid
(CSF) collection (best assessed on axial images, however),
and size of the prepontine cistern (normal, or enlarged if
wider than twice the cross-sectional diameter of the
basilar artery).
The superior cerebellar peduncles (SCP)w e r ee v a l u -
ated on axial images for width (minimally or obviously
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Page 2 of 14thickened), length (normal, or very elongated if almost
equally as long as the posterior fossa), symmetry (sym-
metric or asymmetric), morphology (smooth or irregular
contour), and axial orientation (parallel, A-like or diver-
gent course, V-like or convergent course, or curved) as
well as sagittal orientation (horizontal as typically in
JSRD or ascending when the angle between the brain-
stem and SCP is greater than 90°). The size of the inter-
peduncular fossa was assessed and graded as minimally
or obviously deepened. The cerebral peduncles forming
the “crown” of the molar tooth were evaluated for asym-
metry on axial images.
The brainstem was assessed on sagittal images. The
mesencephalon was evaluated regarding morphology
(normal or abnormal), length (normal, shortened, or
elongated), and width (normal, thinned, or thickened).
The presence of pre-mesencephalic grey matter hetero-
topias lying within the interpeduncular fossa was ascer-
tained. The morphology of the tectum, pons,a n d
medulla (normal or abnormal) as well as the width of
pons and medulla (normal, reduced, or enlarged) were
studied.
Cephaloceles in two locations were evaluated: occipi-
tally and at the level of the foramen magnum.
Supratentorial image analysis
The supratentorial evaluation included a search for
migrational disorders (particularly polymicrogyria and
heterotopias), midline defects (dysgenesis of the corpus
callosum and absence of the septum pellucidum), hippo-
campal malrotation, ventriculomegaly (as an enlarge-
ment of the lateral ventricles without signs of increased
intracranial pressure), hypothalamic hamartoma,
absence of the pituitary gland, fusion of the thalami, pre-
sence of a cavum Vergae and temporal lobe hypoplasia,
and white matter signal abnormalities (focal or diffuse).
Clinical analysis
Detailed information about neurological and dysmorphic
features, involvement of other organs, and neurodeve-
lopmental/neurocognitive outcomes were provided by
review of the clinical history and updated clinical-neuro-
logical follow-up examination.
The neurological features assessed included truncal
and limb ataxia, muscular hypotonia, ocular motor
apraxia, nystagmus, and strabismus. Additionally, we
searched for a history of neonatal breathing abnormal-
ities and epileptic seizures. We characterized the type of
oral findings (tongue hamartoma(s), multiple prominent
frenula, cleft lip and/or palate, and upper lip notch) and
polydactyly (pre-, meso-, or postaxial as duplication of
the first, second to fourth, and fifth digit or ray, respec-
tively) to report their frequency. We also assessed typi-
cal JSRD craniofacial dysmorphic features such as broad
nasal tip, frontal bossing, hypertelorism, and ptosis.
Associated involvement of other organs was explored
with particular attention to the kidneys (nephronophthi-
sis and cystic dysplastic kidneys), eyes (retinal dystrophy,
congenital retinal blindness, and uni- or bilateral colo-
bomas of the iris, choroidea, or retina), and liver (conge-
nital liver fibrosis resulting from ductal plate
malformation).
Finally, we evaluated the cognitive, motor, and lan-
guage outcomes. If possible, formal neuropsychological
testing with assessment of the intelligence quotient (IQ)
was performed. Otherwise, the developmental stage was
estimated from the patient’s history, clinical observa-
tions, and kindergarten or school reports.
Genetic studies
Most patients included in this study had undergone
mutation analysis of some JSRD causative genes as part
of previous genetic screenings on large JSRD cohorts
[22-28] or in subsequent research studies, following the
same mutation screening protocols. The two siblings
from consanguineous parents (patients 12 and 13, Table
1) underwent genome-wide homozygosity mapping
using a GeneChip SNP-array 6.0 platform (Affymetrix,
Santa Clara, CA, USA), as previously reported [29].
Results
Patient characteristics
Fifteen patients fulfilled the inclusion criteria. Addition-
ally, the brother of patient 12 has been included, pre-
senting with tongue hamartomas, postaxial polydactyly
of all limbs, bilateral choroidal and retinal colobomas,
severe cognitive impairment, and similar craniofacial
phenotype, although no MRI was performed. Overall, 16
patients could be included in the study (11 males and 5
females, Table 1). Our cohort included two siblings and
one pair of twins, from different families. The patients
originated from Italy (n = 5), Germany (n = 3), Israel (n
=2 ) ,S w i t z e r l a n d( n=2 ) ,B o s n i a( n=1 ) ,C y p r u s( n=
1), Sweden (n = 1), and Turkey (n = 1). Parental con-
sanguinity was observed in two families (patients 4, 12,
and 13). Neuroimaging findings of patients 1, 2, and 6
have been included in previous reports [21]. At the last
follow-up at the median age of 10.5 years (mean 11.5
years, range 2.5 months to 28.4 years), 14 patients were
alive. One patient died at the age of 2.5 months due to
severe apneas that necessitated repeated resuscitation;
another patient died at the age of 1.8 years due to severe
pneumonia and septic shock. Postmortem examinations
were not performed.
Neuroimaging
MRIs of 15 patients were available for evaluation. All
patients underwent MRI at their local hospital for clini-
cal indications. At the time of the MRIs, the median age
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22.2 years). In all cases the MRI examinations included
at least axial and sagittal T1- and T2-weighted MRI.
Infratentorial findings
Infratentorial neuroimaging findings are summarized in
Table 2. The hypoplasia of the cerebellar vermis was
severe in ten patients (67%) and moderate in five (33%)
(Figure 1). The vermian remnants appeared dysplastic in
all patients (Figure 1). The volume of the cerebellar
hemispheres was reduced in six patients (40%) and their
folial organization was abnormal in eight (53%). The
size of the posterior fossa was enlarged in ten patients
(67%) (Figure 1) and in seven patients (47%) an
increased amount of retrocerebellar CSF collection was
present.
The SCP were asymmetric in five patients (33%) and
in one patient their contour was irregular, showing
some notches. The axial orientation of the SCP was
variable, the sagittal orientation was horizontal in seven
patients (47%) and ascending in eight (53%) (Figure 2).
The cerebral peduncles were asymmetric in three
patients (20%) giving them the appearance of a decaying
molar tooth on axial images.
Abnormalities in size and/or shape of the brainstem
w e r ef o u n di ne l e v e np a t i e n t s (73%) (Figure 1). In two
Table 1 Key clinical and neuroimaging findings in 16 patients with OFD VI
Patients Age at
last
follow-up
(years)
Oral findings Polydactyly MTS Hypothalamic
hamartoma
Additional
features
Tongue
hamartomas
Multiple
frenula
Cleft
lip/
palate
Upper
lip
notch
Hand
right
Hand
left
Foot
right
Foot
left
1 28.4 + - - - Preaxial Preaxial Preaxial Preaxial + - Dysplastic
kidney
2 0.2° - + - - Postaxial Postaxial - - + + Morning glory
anomaly
3 4.4 + + - - Postaxial Postaxial Preaxial Preaxial + + ASD, short
stature (no
endocrine
dysfunctions)
4 5.5 - - + - Postaxial Postaxial Postaxial Postaxial + - Retinal
colobomas
5 1.8° + - + - ---- + - -
6* 16.5 + - - - - Postaxial - Postaxial + - Choroidal
colobomas,
optic atrophy
7* 16.5 + - + - Postaxial Postaxial - - + - Choroidal
colobomas,
optic atrophy
8 0.6 + - - - Postaxial Postaxial Postaxial Postaxial + - -
9 7.1 + - - - Postaxial Postaxial - - + - High grade
myopia
10 22.4 + - - - Postaxial - Preaxial Preaxial + - -
11 9.3 + + - + Mesaxial Preaxial Preaxial Preaxial + + Hirschsprung
disease
12** 17.9 - - + - - Postaxial - - + - Choroidal and
retinal
colobomas, LCA,
NPHP
13** 10.0 + - - - Postaxial Postaxial Postaxial Postaxial n.a. n.a. Choroidal and
retinal
colobomas, LCA
14 17.0 + - - - - - Preaxial Preaxial + - -
15 17.7 + - + + Mesaxial Mesaxial Preaxial Preaxial + + Bicuspid aortic
valve
16 2.0 + + - + Postaxial Postaxial Preaxial Preaxial + - -
ASD, Atrial septal defect; LCA, Leber’s congenital amaurosis; MTS, Molar tooth sign; n.a., not applicable; NPHP, nephronophthisis; OFD VI, Oral-Facial-Digital
Syndrome type VI; *, Twins with heterozygous c.517G > A mutation within the AHI1 gene; **, Siblings; °, died.
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sent (Figure 3). Two different locations of cephaloceles
(occipitally and at the level of the foramen magnum)
were distinguished.
Supratentorial findings
Supratentorial neuroimaging findings are summarized in
Table 3. Seven patients had hippocampal malrotation
(47%). The corpus callosum was dysgenetic (but not
absent) in four patients (27%), the septum pellucidum
was not identified in three (20%). Observed migrational
disorders included bilateral polymicrogyria in three
patients (20%), unilateral closed-lip schizencephaly in
two (13%), and periventricular nodular heterotopias in
one (7%). A ventriculomegaly was present in six patients
(40%) and in four the thalami appeared fused (27%). A
hypothalamic hamartoma was identified in four patients
(27%) (Figure 4). The pituitary gland could be identified
in all patients.
Clinical findings
At the last follow-up, 12 of 16 patients (75%) had gener-
alized muscular hypotonia. Based on age and motor
developmental stage, truncal ataxia could be evaluated
Table 2 Infratentorial neuroimaging findings in 15 patients with OFD VI
Cerebellar and brainstem neuroimaging findings Patients (%)
Posterior fossa Size Enlarged 10 (67%)
Retrocerebellar fluid Marked 7 (47%)
Prepontine cistern Enlarged 4 (27%)
Foramen magnum cephalocele 2 (13%)
Cerebellar hemispheres Size Reduced 6 (40%)
Enlarged 0 (0%)
Morphology Folial disorganization 8 (53%)
Interhemispheric cleft < 1 mm 8 (53%)
1-2 mm 4 (27%)
> 2 mm 3 (20%)
Superior cerebellar peduncles Width Minimally thickened 4 (27%)
Obviously thickened 11 (73%)
Length Very elongated 1 (7%)
Axial orientation Parallel 10 (67%)
A-like 2 (13%)
V-like 0 (0%)
Curved 3 (20%)
Sagittal orientation Horizontal 7 (47%)
Ascending 8 (53%)
Morphology Irregular contour 1 (7%)
Ponto-mesencephalic isthmus Interpeduncular fossa Obviously deepened 14 (93%)
Minimally deepened 1 (7%)
Interpeduncular heterotopia 2 (13%)
Cerebral peduncles Tooth-crown Asymmetric 3 (20%)
Mesencephalon Morphology Dysmorphic 2 (13%)
Length Shortened 0 (0%)
Elongated 2 (13%)
Width Thinned 3 (20%)
Thickened 4 (27%)
Tectum Dysmorphic 10 (67%)
Pons Width Reduced 5 (33%)
Enlarged 0 (0%)
Medulla Morphology Dysmorphic 1 (7%)
Width Reduced 0 (0%)
Enlarged 1 (7%)
OFD VI, Oral-Facial-Digital Syndrome type VI
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ataxia was assessable in five patients and was present in
four (4/5). Ten patients demonstrated ocular motor
apraxia (63%), nine had strabismus (56%; divergent in
eight patients and convergent in one), and three had
nystagmus (19%). Additionally, positive pyramidal signs
were present in two patients (13%) and dyskinetic move-
ments in one (6%). Three patients suffered from epilep-
tic seizures and developed severe scoliosis, respectively
(19%). Seven patients had a history of neonatal respira-
tory abnormalities consisting of alternating short epi-
sodes of apnea and hyperpnoea (44%).
Oral findings (Figures 5, 6) and polydactyly character-
istics (Figure 7) are presented in Table 1. No patient
had a lobed tongue. Craniofacial morphological manifes-
tations included a broad nasal bridge in twelve patients,
hypertelorism and frontal bossing in ten, and bilateral
ptosis in five.
Involvement of other organs was found in eleven
patients (69%, Table 1). Patient 1 had a dysplastic kidney
with preserved renal function. Colobomas were present
in five patients (31%), causing severe visual impairment
in all. No patients had obvious endocrine dysfunctions
based on assessment of growth parameters, external
genitalia, and pubertal development.
Data on motor outcome were available for 15 patients.
At the last follow-up, six patients could not sit or stand
independently, two could sit and roll over but not stand
or walk independently, whereas patient 9 did not show
any motor development at the age of 7 months. Motor
developmental delay was severe in three patients who
started to walk at the age of 6-7 years, and mild in three
other patients who started to walk at the age of 2 years.
Data about developmental or cognitive outcome were
available for 15 patients, and were abnormal in 14
(93%). Based on clinical history and observations, nine
Figure 1 Midsagittal T2-weighted MR images of a 22-year-old woman (A) and a 2-day-old neonate (B), modified from Poretti A et al,
AJNR, 2008, with permission) with OFD VI reveal an enlarged posterior fossa with marked retrocerebellar CSF collection. Additionally,
in both patients the brainstem appears dysmorphic: in A the midbrain is thickened, the tectum dysplastic (white arrow head), and the pons
short; in B there is elongation of the mesencephalon, reduced size of the pons, and dysplasia of the tectum (black arrow head). In both patients
the cerebellar vermis is hypoplastic and its remnants are dysplastic (black arrow in B), the massa intermedia is prominent, and in B a
hypothalamic hamartoma is seen (white arrow) and the pituitary stalk appears thickened (white arrow head).
Figure 2 Parasagittal T2-weighted MR images of a 5-month-old infant (A) and a 22-year-old woman (B) with OFD VI.I nJ S R Dt h eS C P
(white arrows) have a characteristic horizontal sagittal orientation (A). In some patients with OFD VI, however, the SCP (white arrows) have a
clearly ascending orientation (B).
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absent cognitive development. Patients 10 and 14 had a
moderate learning disability with full-scale IQs of 58
and 47 respectively. The developmental quotient of
patient 9 measured at the age of 73 months performing
the Griffiths Mental Developmental Scale was 42, and
patient 16 showed a global developmental delay at the
a g eo f2 2m o n t h s .P a t i e n t1 5w a st h eo n l yo n ew h o s e
cognitive functions were within normal limits: full-scale
IQ was 82, verbal IQ 94, and performance IQ 70 (tested
by means of the revised Wechsler Adult Intelligence
Scale (WAIS-R) at the age of 17.7 years). He attended a
regular school and completed a vocational training
course in graphic design. Additionally, neuropsychologi-
cal assessment in three patients detected difficulties with
spatial cognition including visual-spatial organization
and memory, with impairment in all patients of execu-
tive functions such as planning, abstract reasoning, and
working memory.
Speech and language could be evaluated in 14 of 16
patients based on their age, and all demonstrated some
kind of speech or language impairment. Ten patients
had no expressive speech and were only able to vocalize
sounds. Three patients demonstrated dysarthria impair-
ing speech, one also had severe language difficulties
impairing syntax, and another patient did not develop
speech, although his non-verbal, written development
allowed him to communicate sufficiently. Additionally,
orofacial dyspraxia was reported in three patients (19%),
while three other patients had severe dysphagia necessi-
tating a gastrostomy feeding tube.
Genetic findings
DNA of 13 patients was available for genetic analysis.
Pathogenic mutations in the following JSRD genes were
excluded: INPP5E and TMEM216 (12 probands),
TMEM67 and RPGRIP1L (10 probands), CEP290 (9 pro-
bands), AHI1 (4 probands). In both twins (patients 6
and 7) we found a heterozygous c.517G > A mutation
in the AHI1 gene, which corresponded at the protein
level to the p.A173T missense change. The homozygous
NPHP1 deletion was excluded in all probands. Finally,
genome-wide homozygosity mapping in the two siblings
12 and 13 allowed us to exclude linkage to all known
JSRD loci. Mutation analysis of the GLI3 gene has not
been performed in any patient.
Discussion
The Oral-Facial-Digital Syndrome type VI (OFD VI) or
Váradi-Papp syndrome was originally described as the
combination of polydactyly (typically mesoaxial with Y-
shaped metacarpals, but also pre- and postaxial), cleft
lip/palate, lingual nodules, prominent oral frenula, and
cognitive impairment in six children from a Hungarian
gypsy colony [17]. The autopsy of one of these children
showed absence of the cerebellar vermis. Subsequent
reports confirmed the cerebellar anomalies as consistent
findings and showed hypothalamic hamartomas as
Figure 3 A, midsagittal and B, axial T2-weighted MR images of a 5-
month-old infant with OFD VI, and C, midsagittal constructive
interference in steady-state (CISS) and D, axial T2-weighted MR
images of a 2-year old child with OFD VI.I nb o t hp a t i e n t st h e r ei sa
grey matter isointense, nodular tissue mass in the interpeduncular fossa
representing an interpeduncular heterotopia (black arrows). Additionally, C
demonstrates a hypothalamic hamartoma (white arrow) and a horizontal
septum at the distal end of the Sylvian aqueduct is noted on A.
Table 3 Supratentorial neuroimaging findings in 15
patients with OFD VI
Supratentorial neuroimaging findings Patients (%)
Hippocampal malrotation 7 (47%)
Ventriculomegaly 6 (40%)
Callosal dysgenesis 4 (27%)
Fused thalami 4 (27%)
Hypothalamic hamartoma 4 (27%)
Absent septum pellucidum 3 (20%)
Polymicrogyria 3 (20%)
Schizencephaly 2 (13%)
Heterotopias (periventricular, subcortical) 1 (7%)
Occipital cephalocele 1 (7%)
White matter signal abnormality (diffuse or focal) 1 (7%)
Cavum Vergae 1 (7%)
Temporal lobe hypoplasia 1 (7%)
OFD VI, Oral-Facial-Digital Syndrome type VI
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first to report the MTS in two patients with OFD VI
[18]. Gleeson et al included OFD VI as a subtype of
JSRD and the MTS became a mandatory diagnostic cri-
terion of OFD VI [8].
Neuroimaging
In a recent study of neuroimaging in 75 patients with
JSRD, we failed to show a specific correlation between
neuroimaging and clinical phenotype or genotype in
JSRD, but we noted that the four OFD VI patients
demonstrated a similar and more severe neuroimaging
pattern [21]. Indeed, this preliminary evidence was con-
firmed in the present study. An enlarged posterior fossa
and a marked retrocerebellar CSF collection were pre-
sent in about 70% and 50% of our OFD VI patients
respectively, and were more frequent than in other
JSRD subgroups. Moreover, in 40% of the OFD VI
patients the cerebellar hemispheres appeared hypoplas-
tic, while in other JSRD subgroups their size was mostly
normal [7,21,31]. In OFD VI patients we found two
additional MTS characteristics, not previously described:
Figure 4 A, midsagittal, B, coronal, and C, axial T2-weighted MR image of a 2-day-old neonate with OFD VI show a hypothalamic
hamartoma (white arrow in A, black arrow in B, and thick white arrow in C). Also shown are significant vermian hypoplasia and dysplasia
(black arrow in A), enlarged fourth ventricle and posterior fossa, the characteristic MTS (thin white arrow in C), elongation of the mesencephalon,
reduced size of the pons, thin corpus callosum, absent of the left leaf of the septum pellucidum, and a thickened pituitary stalk (white arrow
head in A; modified from Poretti A et al, AJNR, 2008, with permission). D, midsagittal and E, coronal T2-weighted MR image of a 2.3-year-old boy
with OFD VI show a left paramedian hypothalamic hamartoma (black arrow). Moreover, D shows hypoplasia and dysplasia of the cerebellar
vermis and enlargement of the fourth ventricle.
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Page 8 of 14an ascending course and an irregular (dysplastic) con-
tour of the SCP. Abnormalities in size and/or shape of
the brainstem have been found in about 70% of the
OFD VI patients, far more commonly than in the other
JSRD subgroups (about 30%).
Supratentorial abnormalities have been reported occa-
sionally in OFD VI, including absence of the pituitary
gland [18], migration disorders [32], occipital encephalo-
cele [33,34], or hypothalamic hamartoma [8,19,20,30,32,
35,36]. In our cohort, however, supratentorial abnormal-
ities were present in more than two-thirds of the patients,
compared with about one-third of patients in other JSRD
subgroups [21]. Interestingly, in four OFD VI patients we
found fused thalami, which has not been reported pre-
viously in JSRD and is a typical neuroimaging finding in
holoprosencephaly [37]. The relevance of hypothalamic
hamartomas in OFD VI will be discussed below.
Neurological and cognitive outcome
In OFD VI, not only the neuroimaging pattern but also
the impairment of neurological and cognitive outcome
is more severe than in other JSRD subgroups. Indeed,
about 50% of our patients did not learn to walk and
about 70% did not develop intelligible speech, compared
with only 12-33% and 27% respectively [38,39]. In other
J S R Ds u b g r o u p se p i l e p s yi sr a r ei nt h ea b s e n c eo fa s s o -
ciated migration abnormalities [4]. Three patients in our
study had epileptic seizures and only one had a migra-
tion disorder, suggesting that a higher incidence of epi-
lepsy may also be part of the more severe neurological
phenotype.
Developmental delay and/or cognitive impairment of
variable degrees are present in almost all patients with
JSRD [5,40] and a normal full scale IQ was only
reported in two exceptional patients [5,41]. In OFD VI,
developmental delay and/or cognitive impairment were
considered to be key features in the original report [17].
Four patients were shown to have a developmental quo-
tient of 26-50 [18,19,30] and a full scale IQ of 46 was
reported in another patient [32]. Normal cognitive func-
tions (without formal IQ assessment) have only been
reported in one patient, attending a regular school [30].
In our series 14 of 15 patients had abnormal cognitive
development or functions, thus matching the previous
reports. In the majority of the patients the profound
degree of learning disabilities did not allow us to per-
form a neuropsychological examination. Formal IQ
assessment was only possible in three patients. Two had
Figure 5 A, tongue hamartomas (black arrows), B, additional prominent oral frenula (black arrows), and C, cleft palate in patients with
OFD VI.
Figure 6 A, sagittal T1-weighted and B, sagittal T2-weighted MR image of a 2-week-old newborn with OFD VI demonstrate a T1-
isointense (white arrow on A) and T2-hyperintense (white arrow on B) tissue lesion on the surface of the posterior part of the
tongue, representing a tongue hamartoma.
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Page 9 of 14moderate cognitive impairment (full scale IQs of 58 and
47), while cognitive functions were within normal limits
in only one patient (full scale IQ of 82). The frequency
of cognitive impairment and the rarity of a normal IQ
are similar in OFD VI and other JSRD subgroups. The
level of cognitive impairment, however, appears to differ:
in this study, 64% of the patients had a profound cogni-
tive impairment with almost absent cognitive develop-
ment compared with 30% in other JSRD subgroups [38].
The higher severity of both neuroimaging pattern and
impairment of neurological and cognitive outcome in
OFD VI compared with other JSRD subgroups might be
explained by a causal correlation between these findings.
Involvement of other organs
In previous reports, involvement of eyes [8,42] or kid-
neys [43,44] has only been reported in four OFD VI
patients. In our cohort, involvement of other organs
was more common and present in 69% of the patients.
Ocular involvement, mostly as a coloboma, was pre-
sent in 50% of the patients, whereas our findings con-
firm that renal involvement is rarely associated with
OFD VI and liver involvement is not a feature of OFD
VI. Due to the young median age of the present
patient cohort renal and/or liver involvement may still
develop and no firm conclusions can be drawn at pre-
sent. Interestingly, one patient of our cohort had
Hirschsprung disease, which has also been described in
one patient with “pure” JS [45] and in one patient with
Bardet-Biedl syndrome, another ciliopathy [46]. This
association does not seem to be coincidental and cilia
have been implicated recently in neural crest develop-
ment [47].
Oral findings
Oral findings were considered as essential clinical hall-
marks for OFD VI [17,30,32,36,44,48]. Single or multiple
tongue hamartomas represent the most common form.
In our cohort, however, three patients did not have ton-
gue hamartomas, but had other oral signs such as multi-
ple frenula or cleft palate. Multiple oral frenula are
specific for OFD VI, whereas cleft lip and/or palate have
been reported in patients within other JSRD subgroups
[2-4]. Three patients in our study had an upper lip
notch, which has been previously reported in two
patients with OFD VI [49,50].
It is arguable whether oral findings are an absolute
criterion for OFD VI. A child with MTS, bilateral
mesoaxial hand-polydactyly, and bilateral big-toe-dupli-
cation, but without oral findings, has been reported [34].
These neuroimaging and limb findings are highly sug-
gestive of OFD VI.
In the single affected male of the second family
reported by Coene et al., JBTS10 and mutation in the
OFD1 gene, an upper lip notch, a deep midline groove
of the tongue and a postaxial polydactyly were described
[51]. He did not have involvement of other organs. His
MRI revealed the MTS, a thickened midbrain and a
foramen magnum cephalocele. Based on the oral find-
ings (upper lip notch), this patient would full-fill the
diagnostic criteria for OFD VI (as discussed below). In
the eight male patients of the other family with JBTS10
and mutations in the OFD1 gene, however, no oral find-
ings, but only postaxial polydactyly in 3 were reported
[51].
Polydactyly
Polydactyly has been reported in several patients with
JSRD [52,53]. The most common form is represented by
postaxial polydactyly variably affecting hands and feet.
In OFD VI, however, polydactyly is present in almost all
patients and its most characteristic forms are a mesoax-
ial hand polydactyly arising from an additional central
metacarpal bone or from a bifid or Y-shaped third
metacarpal bone [17,30,35], and a preaxial foot polysyn-
dactyly with bifid hallux [17,30]. Mesoaxial hand poly-
dactyly is extremely rare and specific for OFD VI among
the JSRD phenotypes, but not consistent in OFD VI: dif-
ferent forms of polydactyly have been previously
reported and also found in this study [17,18,30,44,54].
Patients with mutation in the KIF7 gene in the context
of an acrocallosal or fetal hydrolethalus phenotype were
frequently found to have polydactyly and occasionally
cleft palate, but not mesoaxial polydactyly, tongue
hamartoma, additional frenula, or hypothalamic
Figure 7 A, preaxial poly-syndactyly of the right foot, B,
mesoaxial polydactyly of the right hand, C, X-ray of the left
hand showing a Y-shaped third metacarpal bone, and D,
postaxial polydactyly of the right hand.
Poretti et al. Orphanet Journal of Rare Diseases 2012, 7:4
http://www.ojrd.com/content/7/1/4
Page 10 of 14hamartoma [55]. Postaxial polydactyly has been also
described in patients with JBTS10 and mutation in the
OFD1 gene as discussed above [51].
Hypothalamic hamartomas
Hypothalamic hamartomas are also characteristic of
OFD VI and have not been reported in other JSRD phe-
notypes. However, they are not consistent and pathog-
nomonic for OFD VI. The majority of hypothalamic
hamartomas are sporadic and approximately 5% are
associated with the diagnosis of Pallister-Hall syndrome
(PHS, OMIM 146510) [56-59]. Patients with PHS and
mutations in the GLI3 gene may have also clinical mani-
festations that overlap the OFD VI-phenotype, namely
mesoaxial or postaxial polydactyly and oral findings
including additional frenula, tongue hamartomas, and
cleft palate [60,61]. In PHS patients with a GLI3 muta-
tion however, the MTS has never been reported, and its
presence allows the differentiation of OFD VI from
PHS. Johnston et al. reported two patients with pre-
sumed PHS, a phenotype overlapping OFD, and a MTS
[60], and Avila et al. reported also a similar patient [61];
however, none of these patients carried mutations in the
GLI3 gene. Therefore it remains uncertain whether
these patients have PHS or in fact may be examples of
OFD VI. Furthermore, PHS is inherited in an autosomal
dominant manner and individuals with PHS may have
an affected parent or may have the disorder as the result
of a de novo mutation [59]. On the contrary, OFD VI is
inherited in an autosomal recessive manner.
Hypothalamic hamartomas have also been described
in the holoprosencephaly polydactyly syndrome, Smith-
Lemli-Opitz syndrome type 2, hydrolethalus syndrome,
and cerebro-acro-visceral early lethality (CAVE) multi-
plex syndrome [62]. Finally, they have been recently
found in the short rib-polydactyly syndrome, another
group of disorders associated with mutations in ciliary
genes (Palma-Dias R, personal communication at the
conference on Fetal MRI, Vienna 2010). Additionally,
hypothalamic hamartomas should be distinguished from
interpeduncular heterotopias on the basis of their loca-
tions [63]. Interpeduncular heterotopias were initially
reported in three patients with “pure” JS, but we have
also detected them in two OFD VI patients.
Diagnostic criteria
Based on the literature and the present study, we con-
sider the presence of MTS mandatory to diagnose OFD
VI. MTS has not been described in any other type of
oral-facial-digital syndrome and its presence allows the
differentiation of OFD VI from other types.
The oral findings that are present in OFD VI and dif-
ferentiate OFD VI from the other types of JSRD are ton-
gue hamartomas, multiple frenula, and a midline notch
of the upper lip. Clefting of the upper lip or palate
occurs in OFD VI but has also been reported in other
JSRD subgroups and does not count as a differentiating
sign.
The characteristic limb manifestation of OFD VI is
mesoaxial polydactyly, which does not occur in any
other type of JSRD. Preaxial and postaxial polydactyly
occur both in OFD VI and other types of JSRD and
therefore are not differentiating signs.
Hypothalamic hamartomas are specific for OFD VI as
they have not been reported in any other JSRD type.
Neither MTS, the oral findings, mesoaxial polydactyly,
nor hypothalamic hamartoma are pathognomonic as
each can occur in other entities as well. However, the
present study shows that the combination of MTS with
one (or more) of the three other signs is pathognomonic
for the diagnosis of OFD VI. Therefore we suggest that
these form the diagnostic criteria for OFD VI (Table 4).
We realize that no patient with MTS and hypothalamic
hamartoma but without oral or limb defects has been
described to date, but in theory can occur and then our
criteria would be sufficient for the diagnosis of OFD VI.
We are aware that the suggested diagnostic criteria do
not match the inclusion criteria for this study. We
derived the inclusion criteria from the literature while
the diagnostic criteria are based on the literature and
the present study. Indeed both patient 4 and the siblings
patients 12 and 13 do not fulfill the diagnostic criteria
suggested here (although the siblings fulfill the criteria
together).
The presence or absence of the other findings that can
be present in OFD VI, such as cognitive impairment,
ocular colobomas, and duplicated halluces, does not
affect the diagnosis of OFD VI.
Genetic findings
In two OFD VI patients, including one fetus, a homozy-
gous mutation in the TMEM216 gene was found [28].
However, we failed to identify TMEM216 mutations in
12 patients from our cohort. Sequencing analysis of the
KIF7 gene in six OFD VI patients revealed only one het-
erozygous missense mutation, which was also detected
in two patients with Bardet-Biedl syndrome (each one
also carrying another heterozygous mutation in a BBS
gene), as well as in 3 out of 384 controls [55]. One
Table 4 Diagnostic criteria for OFD VI
Molar tooth sign (MTS)*
and one or more of
1. Tongue hamartoma(s) and/or additional
frenula and/or upper lip notch
2. Mesoaxial polydactyly of one or more
hands or feet
3. Hypothalamic hamartoma
*, MTS is required for the index patient of a family; if MRI is not available,
affected relatives need one of 1-3
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mutation, p.E923KfsX3, in exon 21 of the OFD1 gene
fulfilled our diagnostic criteria for OFD VI [51]. How-
ever, eight male patients with JBTS10 and mutations in
the same gene did not match our suggested diagnostic
criteria [51], and several female patients with OFD VI
have been reported, excluding a predominant X-linked
recessive inheritance. From these preliminary findings, it
appears that neither TMEM216 nor KIF7 or OFD1
represent major genes causative of the OFD VI pheno-
type, and the genetic basis of this condition still remains
elusive.
We also found a heterozygous mutation in the AHI1
gene in the two OFD VI twins included in this study.
This heterozygous mutation, as well as the heterozygous
mutation found in the KIF7 gene, are likely to represent
genetic modifiers of the phenotype. Such modifiers have
previously been reported in JSRD and other ciliopathies
and may explain the phenotypical variability associated
with mutations in the same gene [64,65]. One example
was the identification of heterozygous changes in the
AHI1 or CEP290 genes in individuals with homozygous
NPHP1 deletions, which may lead to a more severe neu-
rological phenotype [66]. In conclusion, to date no
major gene has been consistently associated with OFD
VI and the mutations in the TMEM216 gene remain
occasional. In siblings 12 and 13, with consanguineous
parents, genome-wide homozygosity mapping allowed
all known gene loci to be excluded, suggesting the exis-
tence of a novel gene causative of OFD VI. Whole
exome analysis is currently being carried out in this
family. Should this approach be successful, mutation
analysis in a larger cohort of OFD VI cases will reveal
whether the newly identified gene represents a major
determinant for this specific JSRD phenotype.
Limitations
We are aware of some limitations in our study. Although
this is the largest reported cohort, the number of OFD VI
patients is still small. Additionally, not all JSRD genes
were sequenced in all patients. Moreover, the neuroima-
ging evaluation includes only qualitative, not quantitative
measurements. Finally, a formal neurocognitive evalua-
tion was only performed in a minority of the patients.
Conclusions
This study confirms that the neuroimaging pattern and
the impairment of neurological and cognitive outcome
a r em o r es e v e r ei nO F DV It h a ni no t h e rJ S R Ds u b -
groups. We suggest there is a correlation between the
more severe neuroimaging findings and the more pro-
nounced neurological phenotype/cognitive impairment
in OFD VI. However, this observation will remain spec-
ulative until larger series of patients are reported.
The diagnosis of OFD VI is still currently based on
clinical findings and neuroimaging [67]. In view of the
literature and our cohort, we suggest as diagnostic cri-
teria for OFD VI: MTS and one or more of the fol-
lowing: 1) tongue hamartoma(s) and/or additional
frenula and/or upper lip notch; 2) mesoaxial polydac-
tyly of one or more hands or feet; 3) hypothalamic
hamartoma. These criteria allow the diagnosis to be
made even in the absence of oral findings and/or
polydactyly. The validity of these criteria needs to be
reassessed in additional cohorts of patients and after
the identification of major genetic determinants of
OFD VI.
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